Jayex Investors Webinar | Register for the ‘Jayex Investors Webinar’ 2nd November 2023 at 8am AEST. Register Here

Announcements

Australian Securities Exchange

Document Size
02/04/2024: Suspension from Quotation

The securities of the following entities will be suspended from quotation under Listing Rule 17.5 from the commencement of trading today, Tuesday, 2 April 2024, for not lodging the relevant periodic report by the due date.

 91.71 KB
24/03/2024: Voluntary Suspension

The securities of Jayex Technology Limited (‘JTL’) will be suspended from quotation immediately under Listing Rule 17.2, at the request of JTL, pending the release of its Annual Report for the year ended 31 December 2023.

 245.45 KB
13/03/2024: Final Director's Interest Notice

Jayex outlines Nickolas Harper's interest notice.

 131.54 KB
13/03/2024: Initial Director's Interest Notice

Jayex outlines Michael Chan's interest notice.

 133.43 KB
13/03/2024: Board Changes

Jayex announces the resignation of Mr Nick Harper as Non-Executive Director of the Company, with immediate effect.

 134.67 KB
29/02/2024: Appendix 4E - Preliminary Final Report 310.46 KB
31/01/2024: December 2023 Quarterly Update and Appendix 4C 730.76 KB
29/01/2024: Operational Update 511.86 KB
01/11/2023: Q3 Results and Operational Update October 2023 81.90 MB
01/11/2023: Q3 Results and Operational Update October 2023 2.96 MB
31/10/2023: Quarterly review for the period ended 30th Sept 2023 807.90 KB
30/10/2023: Investor webinar 197.84 KB
12/10/2023: Operational update 222.45 KB
10/10/2023: Proposed issues of security 27.84 KB
10/10/2023: Proposed issues of security 28.60 KB
10/10/2023: Termination of Shine agreement 114.76 KB
31/08/2023: Appendix 4D and half-year financial report 358.56 KB
31/07/2023: Quarterly review for the period ended 30 June 2023 455.74 KB
02/06/2023: Notification regarding unquoted securities - JTL (2) 28.31 KB
02/06/2023: Notification regarding unquoted securities - JTL 28.33 KB
31/05/2023: Results of Annual General Meeting 298.77 KB
31/05/2023: AGM Presentation 2.75 MB
31/05/2023: Chairman's Address to Shareholders 169.48 KB
28/04/2023: Quarterly review for the period ended 31st March 2023 400.71 KB
28/04/2023: Proposed issue of securities - JTL 27.80 KB
28/04/2023: Proposed issue of securities - JTL 26.75 KB
28/04/2023: Notice of annual general meeting/proxy Form 1.11 MB
13/04/2023: Change of director's interest notice 239.26 KB
13/04/2023: Appendix 3Y - late lodgement notice 426.02 KB
30/03/2023: Variation from preliminary final report 228.57 KB
17/03/2023: Notification regarding unquoted securities 28.03 KB
17/03/2023: Notification of cessation of securities 22.20 KB
02/03/2023: Results of general meeting 192.55 KB
02/03/2023: Section 708A cleansing notice 291.12 KB
02/03/2023: Application for quotation of + securities 25.33 KB
21/02/2023: Proposed issue of securities 27.81 KB
03/02/2023: Notice of general meeting 483.41 KB
31/01/2023: Jayex executes binding term sheet for health analytics joint venture with Shine Clinical Ltd 261.90 KB
31/01/2023 Proposed issue of securities 25.36 KB
31/01/2023: Q4 review for period ended 31 December 2022 450.36 KB
30/01/2023: Trading halt 234.30 KB
30/01/2023: Pause in trading 113.89 KB
09/01/2023: Chief Financial Officer resignation 240.49 KB
05/12/2022: Change of director's interest notice 237.15 KB
30/11/2022: Operational update 207.51 KB
25/11/2022: Proposed restructure of convertible notes 213.36 KB
16/11/2022: Director resignation 201.20 KB
16/11/2022: Final director's interest notice 196.29 KB
26/09/2022: Jayex appoints Chief Executive Officer 237.62 KB
30/06/2022: Financial report for the half-year ended - 30 June 2022 767.16 KB
29/08/2022: Variations to convertible note deed & loan agreements 232.75 KB
26/05/2022: Chairman's address to shareholders 151.53 KB
26/05/2022: Results of annual general meeting 252.86 KB
27/04/2022: Correction 31 March 2022 appendix 4C 299.21 KB
27/04/2022: March 2022 quarterly update and appendix 4C 252.25 KB
07/04/2022: Notification of cessation of +securities 21.58 KB
31/03/2022: Variation from preliminary final report 174.80 KB
28.60 KB